The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumMost Popular - The Health Care Select Sector SPDR (XLV), the exchange traded fund (ETF) that tracks the Health Care Select Sector Index, gained $0.03 or 0.07% on … Continue Reading
Read nowQuick Picks - The competition among obesity-drug makers continues to heat up Monday following an announcement from Orexigen Therapeutics (NASDAQ:OREX) that the company may be able to expedite the approval … Continue Reading
Read nowLong Ideas - Questcor Pharmaceuticals (NASDAQ:QCOR) is scheduled to report third quarter earnings Tuesday after the market closes, and the Wall Street Consensus expects revenues (mostly Acthar Gel) … Continue Reading
Read nowLong Ideas - DARA BioSciences (NASDAQ:DARA) released some much-needed positive news Monday morning, reporting the domestic launch of Soltamox, the first oral, liquid formulation of the breast-cancer drug … Continue Reading
Read nowLong Ideas - Canadian-based Nuvo Research (TSE:NRI) announced Monday morning that the FDA has approved its Pliaglis product, a unique local anesthetic designed to minimize pain during aesthetic … Continue Reading
Read nowMost Popular - PropThink published its latest report on Keryx Biopharmaceuticals last week, and on Monday we followed up with some technical discussion. We also included QCOR in … Continue Reading
Read nowShort Ideas - Puma Biotechnology (NYSE:PBYI) uplisted to the New York Stock Exchange from the OTC Bulletin Board on Friday, generating significant trading interest in the stock and a 40% … Continue Reading
Read now
